Adler Real Estate Aktie - ADL

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

Gebot

Fragen

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

0,00

Finanzvolumen

VWAP

AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US

TUSTIN, Calif., Sept. 18 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major assets in...

AMDL Inc. Announces Inauguration of AMDL Diagnostics, Inc.

TUSTIN, Calif., Aug. 20 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in...

AMDL Inc. Announces Second Quarter 2009 Financial Results

TUSTIN, Calif., Aug. 19 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in...

AMDL Inc. Files Notification of Late Filing for Form 10-Q

TUSTIN, Calif., Aug. 14 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a U.S.-based pharmaceutical company with major operations...

AMDL Diagnostics Inc. Presenting at the AACC Annual Meeting and Clinical Lab Expo in Chicago, July 20-23, 2009

Company's VP of Scientific Oversight to present AMDL's Onko-Sure(TM) in vitro diagnostic cancer test to conference attendees TUSTIN, Calif., July...

AMDL Inc. Introduces New Brand Name for Its DR-70 (FDP) In Vitro Diagnostic Cancer Test

TUSTIN, Calif., July 8 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in...

AMDL CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009

TUSTIN, Calif., June 17 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in...

AMDL Inc. Announces Second Closing of Private Placement of Series 2 Senior Notes

TUSTIN, Calif., June 15 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in...

AMDL, Inc. Announces First Quarter 2009 Financial Results

TUSTIN, Calif., May 15 /PRNewswire-FirstCall/ -- AMDL, Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in...

AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer

TUSTIN, Calif., May 13 /PRNewswire-FirstCall/ -- AMDL, Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in...

Zeitraum †	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	DE
4	0	0	0	0	0	DE
12	0	0	0	0	0	DE
26	0	0	0	0	0	DE
52	0	0	0	0	0	DE
156	8.64	8.98	3.66	8037	6.9597106	DE
260	7.05	14.98	3.66	13322	10.12348092	DE

ADL - Frequently Asked Questions (FAQ)

What is the current Adler Real Estate share price?

The current share price of Adler Real Estate is 0,00 €

What is the 1 year trading range for Adler Real Estate share price?

Adler Real Estate has traded in the range of 0,00 € to 0,00 € during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
AMIMedondo Holding AG	0,498 € (91,54%)	100
W4VAlphaGen Intelligence Corp	0,01 € (42,86%)	8,04k
WS90Provaris Energy Ltd	0,0104 € (40,54%)	70k
6XCSoleno Therapeutics Inc	64,00 € (40,47%)	181
MWJNaked Wines Plc	1,016 € (36,01%)	57,86k
YBBCarnavale Resources Ltd	0,0015 € (-50,00%)	6,67k
DZ2FBR Limited	0,005 € (-50,00%)	100k
36GGBM Resources Limited	0,003 € (-33,33%)	29,33k
L09Lithium Energi Exploration Inc	0,007 € (-33,33%)	45,33k
KASHIntellabridge Technology Corp	0,0155 € (-32,61%)	6,91k
FMKEcograf Limited	0,212 € (-18,77%)	5,28M
D7GNel ASA	0,22 € (-2,27%)	3,45M
E3BEutelsat Communications	4,45 € (-7,87%)	2,27M
DMJDynaCERT Inc	0,1245 € (0,40%)	1,43M
3CPXiaomi Corporation	6,195 € (-3,80%)	1,09M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Adler Real Estate AG (ADL)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

ADL Neueste Nachrichten

AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US

AMDL Inc. Announces Inauguration of AMDL Diagnostics, Inc.

AMDL Inc. Announces Second Quarter 2009 Financial Results

AMDL Inc. Files Notification of Late Filing for Form 10-Q

AMDL Diagnostics Inc. Presenting at the AACC Annual Meeting and Clinical Lab Expo in Chicago, July 20-23, 2009

AMDL Inc. Introduces New Brand Name for Its DR-70 (FDP) In Vitro Diagnostic Cancer Test

AMDL CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009

AMDL Inc. Announces Second Closing of Private Placement of Series 2 Senior Notes

AMDL, Inc. Announces First Quarter 2009 Financial Results

AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer

ADL - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Adler Real Estate AG (ADL) Börsenkurse

Adler Real Estate AG (ADL)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

ADL Neueste Nachrichten

AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US

AMDL Inc. Announces Inauguration of AMDL Diagnostics, Inc.

AMDL Inc. Announces Second Quarter 2009 Financial Results

AMDL Inc. Files Notification of Late Filing for Form 10-Q

AMDL Diagnostics Inc. Presenting at the AACC Annual Meeting and Clinical Lab Expo in Chicago, July 20-23, 2009

AMDL Inc. Introduces New Brand Name for Its DR-70 (FDP) In Vitro Diagnostic Cancer Test

AMDL CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009

AMDL Inc. Announces Second Closing of Private Placement of Series 2 Senior Notes

AMDL, Inc. Announces First Quarter 2009 Financial Results

AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer

ADL - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen